- Home
- MHUA
MHUA
Meihua International Medical Technologies Co. Ltd.
as 04-25-2025 4:00pm EST
| Founded: | 1990 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 79.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.40 | EPS Growth: | 29.93 |
| 52 Week Low/High: | $0.25 - $1.47 | Next Earning Date: | 04-25-2025 |
| Revenue: | $96,909,642 | Revenue Growth: | -2.54% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Meihua International Medical Technologies Co. Ltd. News
MHUA Breaking Stock News: Dive into MHUA Ticker-Specific Updates for Smart Investing
PR Newswire
a day ago
Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results
Simply Wall St.
4 months ago
Meihua International Medical Technologies (NASDAQ:MHUA) Is Reinvesting At Lower Rates Of Return
PR Newswire
7 months ago
Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
Simply Wall St.
7 months ago
Meihua International Medical Technologies First Half 2024 Earnings: EPS: US$0.19 (vs US$0.29 in 1H 2023)
PR Newswire
7 months ago
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results
PR Newswire
8 months ago
Meihua International Medical Technologies Co., Ltd. to Present at LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar on August 28, 2024
PR Newswire
9 months ago
Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
Simply Wall St.
9 months ago
Be Wary Of Meihua International Medical Technologies (NASDAQ:MHUA) And Its Returns On Capital
Compare MHUA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MHUA Meihua International Medical Technologies Co. Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.